Qualitative method for dantrolene and a related metabolite in urine
β Scribed by John D. Conklin; R. J. Sobers
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- English
- Weight
- 239 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
A qualitative method is described for the determination of dantrolene, amew skeletal muscle relaxant, and a related nonreduced metabolite in human urine. The method consists of the direct extraction of the drug and the metabolite from urine into nitromethane. Addition of a hyamine hydroxide solution to the solvent extract from urines containing the drug and the metabolite results in a yellow color which is linearly related to the amount of drug and metabolite present. A yellow color is not apparent when the alkaline solution is added to solvent extracts from control urine. The method is specific for dantrolene plus the nonreduced metabolite in the presence of a reduced metabolite. Data obtained from urine specimens, collected from humans receiving sodium dantrolene and analyzed by the qualitative method, are also presented.
Keypbrasea 0 Dantrolene and metabolite-qualitative colorimetric determination in urine 0 Colorimetry-qualitative determination of dantrolene and metabolite in urine * Hitachi model 139.
π SIMILAR VOLUMES
## Abstract In this work, a simple method for the simultaneous determination of cocaine (COC) and five COC metabolites (benzoylecgonine, cocaethylene (CET), anhydroecgonine, anhydroecgonine methyl ester and ecgonine methyl ester) in human urine using CE coupled to MS __via__ electrospray ionization
## Abstract A method is described for the quantitative determination of the cyanogenic glycoside linamarin. A preseparation procedure for urine samples was necessary to remove interfering substances. This was done by solidβphase extraction on a silica column containing cyclohexyl functional groups,
## Abstract Beclomethasone dipropionate (BDP) is a potent proβdrug to beclomethasone (BOH) and is used in the treatment of chronic and acute respiratory disorders in the horse. The therapeutic dose of BDP (325 Β΅g per horse) by inhalation results in very low plasma and urinary concentrations of BDP
## Abstract A specific and rapid liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method was developed and validated for NNAL, a metabolite of the tobaccoβspecific nitrosamine metabolite NNK. The metabolite was detected in smokers' urine with a limit of quantitation (LOQ) of 20 pg ml^β1^